Vikram Karnani
Senior Vice President, Rheumatology Business Unit
immunology
ImmunoGen
Jamaica
Biography
Vikram joined Horizon Pharma in July 2014 as group vice president and general manager, specialty business unit and has been in his current position since February 2017. Prior to joining Horizon, Vikram was with Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, where he served as vice president of the therapeutics and cell therapy business, with a focus on sales, marketing and clinical implementation. He also held various positions in business development, corporate strategy and strategic marketing within Fenwal Inc., a private equity owned global medical device company, that was acquired by Fresenius Kabi.
Research Interest
Vikram joined Horizon Pharma in July 2014 as group vice president and general manager, specialty business unit and has been in his current position since February 2017. Prior to joining Horizon, Vikram was with Fresenius Kabi, a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition, where he served as vice president of the therapeutics and cell therapy business, with a focus on sales, marketing and clinical implementation. He also held various positions in business development, corporate strategy and strategic marketing within Fenwal Inc., a private equity owned global medical device company, that was acquired by Fresenius Kabi.
